Ability of Large Language Models to Extract PD-L1 Biomarker Details From Electronic Health Records
Friday, March 14, 2025
NEW ROCHELLE, N.Y., March 5, 2025 /PRNewswire/ -- A new study, published in the peer-reviewed journal AI in Precision Oncology, examines the ability of large language models (LLMs) to rapidly extract PD-L1 biomarker details from the electronic health record (EHR). Click here to read the article now.
PD-L1 biomarker testing guides cancer treatment decisions. These results are difficult to access because laboratory reports are unstructured and require clinical expertise to interpret.
Aaron Cohen, MD, from Flatiron Health and NYU Langone School of Medicine, and coauthors, applied open-source LLMs to extract seven biomarker details relating to PD-L1 testing from the Flatiron Health US nationwide, EHR-derived database.
"LLMs, fine-tuned with high-quality labeled data, accurately extracted complex PD-L1 test details from EHRs despite considerable variability in cancer type, documentation and time," reported the investigators.
"This study is a prime example of AI's power to find needles in haystacks within massive medical records. By extracting critical biomarker data like PD-L1, AI is helping us provide better care, save valuable time, and improve patient outcomes. I commend these authors for their important work and outstanding manuscript. This is exactly the kind of research we aim to publish in AI in Precision Oncology," says Douglas Flora, MD, Editor-in-Chief of AI in Precision Oncology.
About the Journal
AI in Precision Oncology is the only peer-reviewed journal dedicated to the advancement of artificial intelligence applications in clinical and precision oncology. Spearheaded by Editor-in-Chief Douglas Flora, MD and supported by a diverse and accomplished team of international experts, the Journal provides a high-profile forum for cutting-edge research and front matter highlighting important research and industry-related advances rapidly developing within the field. For complete information, visit the AI in Precision Oncology website.
About the Publisher
Mary Ann Liebert, Inc., a Sage company is a global media company dedicated to publishing and delivering impactful peer-reviewed research in biotechnology and life sciences, specialized clinical medicine, and public health and policy, and technology & engineering. Since its founding in 1980, the company has focused on providing critical insights and content that empower researchers and clinicians worldwide to drive innovation and discovery.
Mary Ann Liebert, Inc. / Genetic Engineering News
Media Contact: Kathryn Ryan
914-740-2250
kryan@liebertpub.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ability-of-large-language-models-to-extract-pd-l1-biomarker-details-from-electronic-health-records-302393655.html
SOURCE Mary Ann Liebert, Inc.
|
|
|
|
|
 |
OrthoMinds, LLC Provides Notice of a Data Security Event | Mar 28, 2025
|
|
ISSAQUAH FINANCIAL PROVIDES NOTICE OF POTENTIAL DATA EVENT | Mar 28, 2025
|
|
Foregoing Banking-as-a-Service: Case study concludes Current's core banking technology provides a key edge in the market | Mar 28, 2025
|
|
O'Shaughnessy Ventures Launches Infinite Books, Names Bestselling Author Jimmy Soni as CEO and Editor in Chief | Mar 28, 2025
|
|
Weekly Recap: 10 Finance Press Releases You Need to See | Mar 28, 2025
|
|
Disrupting Digital Identity: Sentry's Biometric Solution to Stop Fraud | Mar 28, 2025
|
|
Xojo 2025r1 Launches with Linux ARM Support, Web Drag and Drop and Direct App Store Submission | Mar 28, 2025
|
|
Asknoypi: The Ultimate Web Directory Transforming Online Visibility for Businesses | Mar 28, 2025
|
|
Earnest Analytics launches AI-powered data summaries in its online platform, Dash | Mar 28, 2025
|
|
Canon Announces V1 Digital Camera, Reboots Compact Lineup with Video Centric PowerShot V1 Camera, YouTube First Look Video and More Info at B&H | Mar 28, 2025
|
|
|
